MXLMaxLinear, Inc.

$96.15+494% 1Y

Is the business good?

Mixed

The checks split: nothing decisive, though margins compressing.

1 to watch, 1 neutral, 2 without data
Fundamental health (F-score)5 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−7.5 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is MXL?

MaxLinear, Inc. earns −11% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−11%

Return on invested capital · cost of capital 9.0% · 20 points below what the capital costs: growth destroys value

Operating margin
−14%

Operating margin · Semiconductors median 7.5% · 12 months to Q2 2026

Share count, year on year
+12%

Share count, year on year · shareholders own a smaller slice than a year ago

R&D as % of revenue
38%

R&D as % of revenue

Operating margin by fiscal year
YearOperating margin
FY2020−21%
FY20217.3%
FY202216%
FY2023−5.5%
FY2024−62%
FY2025−27%
Details›
Gross margin12 months to Q2 2026
57%
Operating margin12 months to Q2 2026
−14%
Net margin12 months to Q2 2026
−18%
Free cash flow margin
0.58%
R&D as % of revenue
38%
Revenue, trailing twelve months
$569M
Free cash flow, trailing twelve months
$3.3M
Net income, trailing twelve months
−$104M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.